Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone - PubMed (original) (raw)
Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone
Tobie Escher et al. Addict Biol. 2006 Mar.
Abstract
Acamprosate and naltrexone are therapeutically effective drugs that promote abstinence and prevent drinking relapse among alcohol-dependent patients, and dose-dependently decrease alcohol self-administration in animals. The purpose of this experiment was to investigate the behavioral specificity of acamprosate and naltrexone treatment in mice on alcohol drinking elicited in a schedule-induced polydipsia (SIP) task. Food-deprived male C57BL/6J (B6) mice were divided into three groups assigned to a 5% alcohol SIP, water SIP, or a 1-hour limited access regulatory water drinking task. Injections (intraperitoneal) of acute (0, 50, 100, 200, 400 mg/kg) and chronic (2 x 100 mg/kg, 10 days) acamprosate, or naltrexone (0, 1.0, 2.5, 5.0 mg/kg) were administered. Behavioral drug specificity was determined by comparing alterations in alcohol or water consumption in SIP with alterations in limited access drinking. Additionally, drug effects on drinking-specific measures (g/kg consumption and lick efficiency) were compared with those of non-drinking measures (head entries for food and locomotor activity) during SIP. In comparison with saline injections, acute acamprosate (400 mg/kg) reduced both alcohol and water drinking in both SIP and the regulatory drinking conditions, but had no significant effects on non-drinking measures. Chronic administration of acamprosate reduced both alcohol and water drinking during SIP, but did not significantly affect regulatory drinking or non-drinking measures. Naltrexone (1.0, 2.5, 5.0 mg/kg) reduced alcohol and water drinking in both paradigms, and at the highest dose, significantly reduced head entries for food. These results indicate that acamprosate (acute and chronic) and naltrexone are relatively non-selective in their effects on alcohol self-administration in this task.
Similar articles
- Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice.
Heidbreder CA, Andreoli M, Marcon C, Hutcheson DM, Gardner EL, Ashby CR Jr. Heidbreder CA, et al. Addict Biol. 2007 Mar;12(1):35-50. doi: 10.1111/j.1369-1600.2007.00051.x. Addict Biol. 2007. PMID: 17407496 - Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
Kim SG, Han BD, Park JM, Kim MJ, Stromberg MF. Kim SG, et al. Psychiatry Clin Neurosci. 2004 Feb;58(1):30-6. doi: 10.1111/j.1440-1819.2004.01189.x. Psychiatry Clin Neurosci. 2004. PMID: 14678454 - Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice.
Escher T, Call SB, Blaha CD, Mittleman G. Escher T, et al. Psychopharmacology (Berl). 2006 Sep;187(4):424-34. doi: 10.1007/s00213-006-0465-5. Epub 2006 Jul 12. Psychopharmacology (Berl). 2006. PMID: 16835770 - Acamprosate: recent findings and future research directions.
Mann K, Kiefer F, Spanagel R, Littleton J. Mann K, et al. Alcohol Clin Exp Res. 2008 Jul;32(7):1105-10. doi: 10.1111/j.1530-0277.2008.00690.x. Alcohol Clin Exp Res. 2008. PMID: 18540918 Review. - Acamprosate for the treatment of alcohol dependence.
Boothby LA, Doering PL. Boothby LA, et al. Clin Ther. 2005 Jun;27(6):695-714. doi: 10.1016/j.clinthera.2005.06.015. Clin Ther. 2005. PMID: 16117977 Review.
Cited by
- Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats.
Hulin MW, Lawrence MN, Amato RJ, Weed PF, Winsauer PJ. Hulin MW, et al. Alcohol. 2015 Mar;49(2):127-38. doi: 10.1016/j.alcohol.2014.07.024. Epub 2015 Jan 6. Alcohol. 2015. PMID: 25620274 Free PMC article. - Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
Johnson BA. Johnson BA. Biochem Pharmacol. 2008 Jan 1;75(1):34-56. doi: 10.1016/j.bcp.2007.08.005. Epub 2007 Aug 9. Biochem Pharmacol. 2008. PMID: 17880925 Free PMC article. Review. - Mouse parasubthalamic Crh neurons drive alcohol drinking escalation and behavioral disinhibition.
Kreifeldt M, Okhuarobo A, Dunning JL, Lopez C, Macedo G, Sidhu H, Contet C. Kreifeldt M, et al. bioRxiv [Preprint]. 2024 Jul 10:2024.07.06.602357. doi: 10.1101/2024.07.06.602357. bioRxiv. 2024. PMID: 39026704 Free PMC article. Preprint. - Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice.
Kamdar NK, Miller SA, Syed YM, Bhayana R, Gupta T, Rhodes JS. Kamdar NK, et al. Psychopharmacology (Berl). 2007 Jun;192(2):207-17. doi: 10.1007/s00213-007-0711-5. Epub 2007 Feb 2. Psychopharmacology (Berl). 2007. PMID: 17273875 - A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats.
Nielsen CK, Simms JA, Pierson HB, Li R, Saini SK, Ananthan S, Bartlett SE. Nielsen CK, et al. Biol Psychiatry. 2008 Dec 1;64(11):974-81. doi: 10.1016/j.biopsych.2008.07.018. Epub 2008 Sep 6. Biol Psychiatry. 2008. PMID: 18774553 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous